September 18, 2012

Lipid-Lowering Therapy in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis.

.   .   

This meta-analysis of lipid lowering therapy (statin or statin + ezetimibe) in patients with chronic kidney disease (CKD) showed no benefit in renal outcomes but did show a decreased risk of cardiac mortality, cardiovascular events including revascularization and myocardial infarction.

Related Articles:

Chronic Kidney Disease, Vascular Disease/Calcification

Comments are closed.